Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 472481 - 472500 out of 476480 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01XG03) ixazomib | NINLARO 4MG CAP | 3 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01XG03) ixazomib | NINLARO 4MG CAP | 3 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01XH01) vorinostat | ZOLINZA 100MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | MerckSharp&DohmeLLC |
| USA | (L01XH01) vorinostat | ZOLINZA 100MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | MerckSharp&DohmeLLC |
| USA | (L01XJ01) vismodegib | ERIVEDGE 150MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Basal Cell | GenentechUSA,Inc. |
| USA | (L01XJ01) vismodegib | ERIVEDGE 150MG CAP | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Basal Cell | GenentechUSA,Inc. |
| USA | (L01XJ03) glasdegib | DAURISMO 100MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | Pfizer,Inc. |
| USA | (L01XJ03) glasdegib | DAURISMO 100MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | Pfizer,Inc. |
| USA | (L01XJ03) glasdegib | DAURISMO 25MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | Pfizer,Inc. |
| USA | (L01XJ03) glasdegib | DAURISMO 25MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.25MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.25MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.25MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.25MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.35MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.35MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
Pages
